|
BR112019017629A2
(pt)
*
|
2017-03-27 |
2020-04-07 |
Hoffmann La Roche |
receptor de união ao antígeno, polinucleotídeo isolado, vetor, célula t transduzida, métodos para o tratamento de uma doença e para induzir a lise, utilização do receptor e receptor
|
|
CN110526987A
(zh)
*
|
2018-05-25 |
2019-12-03 |
深圳宾德生物技术有限公司 |
靶向cd133的嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用
|
|
CN109735500B
(zh)
*
|
2019-01-25 |
2023-05-16 |
苏州茂行生物科技有限公司 |
一种分泌型靶向cd133的car-t细胞及其制备方法和应用
|
|
BR112021022682A2
(pt)
|
2019-05-14 |
2022-02-22 |
Provention Bio Inc |
Métodos e composições para prevenir diabetes do tipo 1
|
|
EP3976649A4
(en)
*
|
2019-05-31 |
2022-12-14 |
The Johns Hopkins University |
B-SPECIFIC IL-6Ra/IL-8R BINDING AGENTS TO BLOCK MIGRATION OF CANCER CELLS
|
|
EP3976644A4
(en)
|
2019-05-31 |
2022-12-14 |
The Johns Hopkins University |
BI-SPECIFIC LIAISONS
|
|
CN113912694B
(zh)
*
|
2019-07-24 |
2023-05-30 |
暨南大学 |
靶向cd133的结合蛋白和应用
|
|
US12006366B2
(en)
|
2020-06-11 |
2024-06-11 |
Provention Bio, Inc. |
Methods and compositions for preventing type 1 diabetes
|
|
CN111529690B
(zh)
*
|
2020-06-17 |
2023-03-31 |
中国科学院昆明动物研究所 |
人cd133蛋白1-108肽段的新用途
|
|
CN114057875B
(zh)
*
|
2020-07-31 |
2023-05-05 |
北京市神经外科研究所 |
抗cd133的单链抗体及其在制备治疗肿瘤的药物中的用途
|
|
JP2023543017A
(ja)
*
|
2020-09-27 |
2023-10-12 |
ジェネンテック， インコーポレイテッド |
ハイスループットマルチパラメータ免疫細胞エンゲージャースクリーニングアッセイ
|
|
TW202237827A
(zh)
|
2020-12-03 |
2022-10-01 |
美商世紀治療股份有限公司 |
經基因工程改造之細胞及其用途
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
JP2024500847A
(ja)
|
2020-12-18 |
2024-01-10 |
センチュリー セラピューティクス，インコーポレイテッド |
適合可能な受容体特異性を有するキメラ抗原受容体システム
|
|
US12404315B2
(en)
|
2020-12-21 |
2025-09-02 |
Allogene Therapeutics, Inc. |
Protease-activating CD45-gate CAR
|
|
MX2023008809A
(es)
|
2021-01-29 |
2023-08-04 |
Allogene Therapeutics Inc |
ATENUACIÓN O INACTIVACIÓN DE UNO O MÁS DE TAP2, NLRC5, ß2M, TRAC, RFX5, RFXAP Y RFXANK PARA MITIGAR EL RECONOCIMIENTO DE CÉLULAS T DE PRODUCTOS CELULARES ALOGÉNICOS.
|
|
WO2022251253A1
(en)
|
2021-05-24 |
2022-12-01 |
Provention Bio, Inc. |
Methods for treating type 1 diabetes
|
|
AU2022287014A1
(en)
*
|
2021-06-04 |
2023-12-07 |
Amgen Inc. |
T cell engager molecules and uses thereof
|
|
CN114316050B
(zh)
*
|
2021-12-24 |
2022-11-11 |
北京市神经外科研究所 |
Cd133抗体、嵌合抗原受体及其应用
|
|
CN114213537B
(zh)
*
|
2021-12-24 |
2022-06-14 |
北京市神经外科研究所 |
Cd133抗体、嵌合抗原受体及其应用
|
|
WO2023133595A2
(en)
|
2022-01-10 |
2023-07-13 |
Sana Biotechnology, Inc. |
Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
|
|
CN119654406A
(zh)
|
2022-07-29 |
2025-03-18 |
艾洛基治疗公司 |
具有降低的基因表达以减轻免疫细胞识别的经工程化的细胞
|
|
WO2024040195A1
(en)
|
2022-08-17 |
2024-02-22 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
WO2024081820A1
(en)
|
2022-10-13 |
2024-04-18 |
Sana Biotechnology, Inc. |
Viral particles targeting hematopoietic stem cells
|
|
WO2024119157A1
(en)
|
2022-12-02 |
2024-06-06 |
Sana Biotechnology, Inc. |
Lipid particles with cofusogens and methods of producing and using the same
|
|
WO2024220597A2
(en)
|
2023-04-18 |
2024-10-24 |
Sana Biotechnology, Inc. |
Digital droplet based assay for detecting replication competent lentiviral vector
|
|
AU2024274792A1
(en)
|
2023-05-23 |
2025-10-23 |
Sana Biotechnology, Inc. |
Tandem fusogens and related lipid particles
|
|
AU2024279278A1
(en)
|
2023-05-31 |
2025-12-18 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2025056957A1
(en)
*
|
2023-09-15 |
2025-03-20 |
Jimenez Mendoza, Dimas |
Peptide based medicines for treating cancer
|
|
WO2025076113A1
(en)
|
2023-10-05 |
2025-04-10 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids with conserved spacing and lipid nanoparticles
|
|
IL327045A
(en)
|
2023-10-05 |
2026-05-01 |
Capstan Therapeutics Inc |
Structure-restricted ionizable cationic lipids and lipid nanoparticles
|
|
AU2024372734A1
(en)
|
2023-10-30 |
2026-04-16 |
Allogene Therapeutics, Inc. |
Engineered cells
|
|
WO2025184529A1
(en)
|
2024-03-01 |
2025-09-04 |
Sana Biotechnology, Inc. |
Viral particles with fusogen display and related compositions and methods
|
|
WO2025217454A2
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids and lipid nanoparticles
|
|
WO2025217452A1
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|
|
CN118108849B
(zh)
*
|
2024-04-28 |
2024-06-25 |
苏州睿瀛生物技术有限公司 |
一种抗cd33的纳米抗体制备方法和抗体的荧光标记流式应用
|